145 related articles for article (PubMed ID: 2182759)
1. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease.
Landin K; Tengborn L; Smith U
J Intern Med; 1990 Apr; 227(4):273-8. PubMed ID: 2182759
[TBL] [Abstract][Full Text] [Related]
2. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors.
Landin K; Tengborn L; Smith U
J Intern Med; 1991 Feb; 229(2):181-7. PubMed ID: 1900072
[TBL] [Abstract][Full Text] [Related]
3. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.
Landin K; Stigendal L; Eriksson E; Krotkiewski M; Risberg B; Tengborn L; Smith U
Metabolism; 1990 Oct; 39(10):1044-8. PubMed ID: 2215252
[TBL] [Abstract][Full Text] [Related]
4. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
[TBL] [Abstract][Full Text] [Related]
5. [The effect of doxazosin on blood pressure, lipids, fibrinogen and plasminogen activator inhibitor. A comparative study among smokers and non-smokers with essential hypertension].
Daae LN; Kierulf P; Brusletto B; Westheim A; Holme I; Syvertsen JO
Tidsskr Nor Laegeforen; 1991 Apr; 111(9):1102-5. PubMed ID: 1827216
[TBL] [Abstract][Full Text] [Related]
6. Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group.
Agewall S
J Intern Med; 1999 Nov; 246(5):489-95. PubMed ID: 10583718
[TBL] [Abstract][Full Text] [Related]
7. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
Gürlek A; Bayraktar M; Kirazli S
Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
[TBL] [Abstract][Full Text] [Related]
8. Hypertension and the metabolic cardiovascular syndrome: special reference to premenopausal women.
Os I; Nordby G
J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S15-21. PubMed ID: 1283764
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
[TBL] [Abstract][Full Text] [Related]
10. Effects of short-term exercise training on plasminogen activator inhibitor (PAI-1).
Bodary PF; Yasuda N; Watson DD; Brown AS; Davis JM; Pate RR
Med Sci Sports Exerc; 2003 Nov; 35(11):1853-8. PubMed ID: 14600550
[TBL] [Abstract][Full Text] [Related]
11. Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variables.
Cigolini M; Targher G; Seidell JC; Tonoli M; Schiavon R; Agostino G; De Sandre G
J Hypertens; 1995 Jun; 13(6):659-66. PubMed ID: 7594424
[TBL] [Abstract][Full Text] [Related]
12. Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the Northern Sweden MONICA Study.
Eliasson M; Asplund K; Evrin PE; Lindahl B; Lundblad D
Metabolism; 1994 Dec; 43(12):1579-86. PubMed ID: 7990715
[TBL] [Abstract][Full Text] [Related]
13. Plasma insulin, plasminogen activator inhibitor, and ankle-brachial systolic blood pressure ratio in overweight hypertensive subjects.
Achimastos A; Brahimi M; Raison J; Billaud E; Ayache M; Moatti N; Safar ME
J Hum Hypertens; 1999 May; 13(5):329-35. PubMed ID: 10376851
[TBL] [Abstract][Full Text] [Related]
14. Elevation of plasminogen activator inhibitor 1 in borderline hypertension is linked to concomitant metabolic disturbances.
Lemne C; De Faire U
Eur J Clin Invest; 1996 Aug; 26(8):692-7. PubMed ID: 8872066
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension.
Toft I; Bønaa KH; Ingebretsen OC; Nordøy A; Birkeland KI; Jenssen T
Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):553-9. PubMed ID: 9102176
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
17. High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults.
Johansson JO; Landin K; Tengborn L; Rosén T; Bengtsson BA
Arterioscler Thromb; 1994 Mar; 14(3):434-7. PubMed ID: 8123648
[TBL] [Abstract][Full Text] [Related]
18. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity. CaptISM Study Group. Captopril Insulin Sensitivity Multicenter Study Group.
Raccah D; Pettenuzzo-Mollo M; Provendier O; Boucher L; Cozic JA; Gorlier R; Huin P; Sicard J; Vague P
Am J Hypertens; 1994 Aug; 7(8):731-8. PubMed ID: 7986464
[TBL] [Abstract][Full Text] [Related]
20. Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents.
Gallistl S; Sudi KM; Borkenstein M; Troebinger M; Weinhandl G; Muntean W
Int J Obes Relat Metab Disord; 2000 Nov; 24(11):1459-64. PubMed ID: 11126343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
